MedAlliance Receives Fourth FDA Breakthrough Device Designatio...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NYON, Switzerland, March 4, 2021 /PRNewswire-AsiaNet/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR(TM), its ...
Authors: LATEST ASIANET NEWS RELEASES